167 related articles for article (PubMed ID: 8172680)
1. MHC class II antigen processing: biology of invariant chain.
Sant AJ; Miller J
Curr Opin Immunol; 1994 Feb; 6(1):57-63. PubMed ID: 8172680
[TBL] [Abstract][Full Text] [Related]
2. The bio-logical role of invariant chain (Ii) in MHC class II antigen presentation.
Nordeng TW; Bakke O
Immunol Lett; 1994 Dec; 43(1-2):47-55. PubMed ID: 7737689
[TBL] [Abstract][Full Text] [Related]
3. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
Busch R; Rinderknecht CH; Roh S; Lee AW; Harding JJ; Burster T; Hornell TM; Mellins ED
Immunol Rev; 2005 Oct; 207():242-60. PubMed ID: 16181341
[TBL] [Abstract][Full Text] [Related]
4. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
Cheng PC; Steele CR; Gu L; Song W; Pierce SK
J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
[TBL] [Abstract][Full Text] [Related]
5. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
[TBL] [Abstract][Full Text] [Related]
6. MHC class II expression is regulated in dendritic cells independently of invariant chain degradation.
Villadangos JA; Cardoso M; Steptoe RJ; van Berkel D; Pooley J; Carbone FR; Shortman K
Immunity; 2001 Jun; 14(6):739-49. PubMed ID: 11420044
[TBL] [Abstract][Full Text] [Related]
7. Exogenous CLIP localizes into endocytic compartment of cells upon internalization: implications for antigen presentation by MHC class II molecules.
Mukherjee R; Chaturvedi P; Lee-Chan E; Singh B
Mol Immunol; 2008 Apr; 45(8):2166-76. PubMed ID: 18279957
[TBL] [Abstract][Full Text] [Related]
8. MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation.
Malcherek G; Wirblich C; Willcox N; Rammensee HG; Trowsdale J; Melms A
Eur J Immunol; 1998 May; 28(5):1524-33. PubMed ID: 9603457
[TBL] [Abstract][Full Text] [Related]
9. MHC class II molecules on the move for successful antigen presentation.
Rocha N; Neefjes J
EMBO J; 2008 Jan; 27(1):1-5. PubMed ID: 18046453
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of major histocompatibility complex class II compartments during B cell receptor-mediated cell activation.
Lankar D; Vincent-Schneider H; Briken V; Yokozeki T; Raposo G; Bonnerot C
J Exp Med; 2002 Feb; 195(4):461-72. PubMed ID: 11854359
[TBL] [Abstract][Full Text] [Related]
11. A central role for HSC70 in regulating antigen trafficking and MHC class II presentation.
Deffit SN; Blum JS
Mol Immunol; 2015 Dec; 68(2 Pt A):85-8. PubMed ID: 25953005
[TBL] [Abstract][Full Text] [Related]
12. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
13. Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function.
Germain RN
Semin Immunol; 1995 Dec; 7(6):361-72. PubMed ID: 8775462
[TBL] [Abstract][Full Text] [Related]
14. Introducing endogenous antigens into the major histocompatibility complex (MHC) class II presentation pathway. Both Ii mediated inhibition and enhancement of endogenous peptide/MHC class II presentation require the same Ii domains.
Frauwirth K; Shastri N
Immunology; 2001 Apr; 102(4):405-15. PubMed ID: 11328374
[TBL] [Abstract][Full Text] [Related]
15. Pathways of antigen processing.
Blum JS; Wearsch PA; Cresswell P
Annu Rev Immunol; 2013; 31():443-73. PubMed ID: 23298205
[TBL] [Abstract][Full Text] [Related]
16. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
Adams S; Humphreys RE
Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997
[TBL] [Abstract][Full Text] [Related]
17. MHC II and the endocytic pathway: regulation by invariant chain.
Landsverk OJ; Bakke O; Gregers TF
Scand J Immunol; 2009 Sep; 70(3):184-93. PubMed ID: 19703008
[TBL] [Abstract][Full Text] [Related]
18. Intracellular transport and peptide loading of MHC class II molecules: regulation by chaperones and motors.
Wubbolts R; Neefjes J
Immunol Rev; 1999 Dec; 172():189-208. PubMed ID: 10631947
[TBL] [Abstract][Full Text] [Related]
19. MHC class II-restricted antigen processing and presentation.
Pieters J
Adv Immunol; 2000; 75():159-208. PubMed ID: 10879284
[No Abstract] [Full Text] [Related]
20. Impaired processing and presentation by MHC class II proteins in human diabetic cells.
Yan G; Shi L; Penfornis A; Faustman DL
J Immunol; 2003 Jan; 170(1):620-7. PubMed ID: 12496451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
